Page last updated: 2024-08-21

quinazolines and EHS Tumor

quinazolines has been researched along with EHS Tumor in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, M; Lepler, S; Pampo, C; Rice, L; Siemann, DW1
Fudenberg, HH; Hynes, JB; Tsang, KY1
Bertino, JR; Chang, YM; Li, WW; Lin, JT; Schweitzer, B1
Atassi, G; Baron, M; Bissery, MC; Cros, S; Gebel-Servolles, P; Giorgi-Renault, S; Lavelle, F; Paoletti, C; Renault, J1

Other Studies

4 other study(ies) available for quinazolines and EHS Tumor

ArticleYear
Impact of the Src inhibitor saracatinib on the metastatic phenotype of a fibrosarcoma (KHT) tumor model.
    Anticancer research, 2010, Volume: 30, Issue:11

    Topics: Animals; Apoptosis; Benzodioxoles; Blotting, Western; Cell Adhesion; Cell Cycle; Cell Movement; Cell Proliferation; Disease Models, Animal; Female; Fibrosarcoma; Fluorescent Antibody Technique; Focal Adhesion Kinase 1; Lung Neoplasms; Mice; Mice, Inbred C3H; Phosphorylation; Quinazolines; Sarcoma, Experimental; src-Family Kinases; Survival Rate; Tumor Cells, Cultured

2010
Effects of 5,8-dideazaisofolic acid (IAHQ) on human tumor cells in culture and on normal and tumor-bearing hamsters.
    Chemotherapy, 1982, Volume: 28, Issue:4

    Topics: Animals; Cell Division; Cell Line; Cricetinae; Cytotoxicity, Immunologic; Drug Resistance; Female; Folic Acid Antagonists; Humans; Lymphocyte Activation; Methotrexate; Neoplasms; Osteosarcoma; Pregnancy; Quinazolines; Sarcoma, Experimental

1982
Prediction of antifolate efficacy in a rat sarcoma model.
    International journal of cancer, 1991, Sep-09, Volume: 49, Issue:2

    Topics: Aminopterin; Animals; Drug Screening Assays, Antitumor; Folic Acid Antagonists; Male; Methotrexate; Methylcholanthrene; Quinazolines; Rats; Sarcoma, Experimental; Thymidylate Synthase; Trimetrexate

1991
Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedione.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:1

    Topics: Animals; Antineoplastic Agents; Aziridines; Breast Neoplasms; Cell Division; Cell Line; Drug Screening Assays, Antitumor; Female; Humans; Leukemia L1210; Leukemia, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Molecular Structure; Neoplasms, Experimental; Quinazolines; Sarcoma, Experimental; Structure-Activity Relationship

1991